Abstract
Objectives
Cardiac troponin (cTn) is the key biomarker for diagnosis of acute coronary syndrome (ACS). We performed a complete assessment of the high-sensitivity cardiac troponin I (hs-cTnI) (CLIA) assay on the analytical performance and clinical diagnostic performance, which was compared with Abbott ARCHITECT hs-cTnI assay.
Methods
Sex-specific 99th percentile upper reference limits (URLs) were determined from a healthy population of 424 males and 408 females. High-sensitivity performance was assessed by examining the imprecision at sex-specific URLs and the detectable results above LoD in a cohort of healthy population. The diagnostic performance of the hs-cTnI (CLIA) assay was validated in a population of 934 patients with suspected ACS.
Results
The 99th percentile URLs were 15.3 ng/L for female, 31.3 ng/L for male and 24.2 ng/L for overall population. The total imprecision near the sex-specific 99th percentile URLs were <5 %. 76.74 % of females, 97.12 % of males and 86.69 % of overall population had cTnI values exceeding the LoD, which met the criteria of high-sensitivity troponin assay. No cross-reactivity or interference was identified. The diagnostic sensitivity, specificity, PPV, NPV, and AUC of hs-cTnI (CLIA) assay were 97.97 , 90.70, 79.02, 99.21 % and 0.9885, respectively, which were comparable to ARCHITECT hs-cTnI assay.
Conclusions
hs-cTnI (CLIA) assay is a high-sensitivity troponin I method with high precision, sensitivity and specificity. The clinical diagnostic performance of hs-cTnI (CLIA) is comparable to the established ARCHITECT hs-cTnI assay. Mindray’s hs-cTnI (CLIA) assay is an attractive alternative for diagnosis of myocardial infarction with a high level of accuracy and safety.
Funding source: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-
Research ethics: The present study carried out at Wuhan Asia Heart hospital (Wuhan, Hubei province, China) was approved by the Ethics Committee in accordance with the Helsinki Declaration.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: The authors declare that there is no conflict of interest.
-
Research funding: This project was supported by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. for financial support. Financial support was not dependent on the results of the study.
References
1. Fathil, MF, Md Arshad, MK, Gopinath, SC, Hashim, U, Adzhri, R, Ayub, RM, et al.. Diagnostics on acute myocardial infarction: cardiac troponin biomarkers. Biosens Bioelectron 2015;70:209–20. https://doi.org/10.1016/j.bios.2015.03.037.Search in Google Scholar PubMed
2. Katrukha, IA. Human cardiac troponin complex. Structure and functions. Biochemistry 2013;78:1447–65. https://doi.org/10.1134/s0006297913130063.Search in Google Scholar PubMed
3. Thygesen, K, Mair, J, Katus, H, Plebani, M, Venge, P, Collinson, P, et al.. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197–204. https://doi.org/10.1093/eurheartj/ehq251.Search in Google Scholar PubMed
4. Mair, J, Morandell, D, Genser, N, Lechleitner, P, Dienstl, F, Puschendorf, B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995;41:1266–72. https://doi.org/10.1093/clinchem/41.9.1266.Search in Google Scholar
5. Mair, J, Genser, N, Morandell, D, Maier, J, Mair, P, Lechleitner, P, et al.. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 1996;245:19–38. https://doi.org/10.1016/0009-8981(95)06168-1.Search in Google Scholar PubMed
6. Roffi, M, Patrono, C, Collet, JP, Mueller, C, Valgimigli, M, Andreotti, F, et al.. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the european society of cardiology (ESC). Eur Heart J 2016;37:267–315. https://doi.org/10.1093/eurheartj/ehv320.Search in Google Scholar PubMed
7. Morrow, DA, Cannon, CP, Jesse, RL, Newby, LK, Ravkilde, J, Storrow, AB, et al.. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552–74. https://doi.org/10.1373/clinchem.2006.084194.Search in Google Scholar PubMed
8. Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, et al.. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:e618–51. https://doi.org/10.1016/j.gheart.2018.08.004.Search in Google Scholar PubMed
9. Eggers, KM, Lindahl, B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 2017;63:223–35. https://doi.org/10.1373/clinchem.2016.261495.Search in Google Scholar PubMed
10. Garg, P, Morris, P, Fazlanie, AL, Vijayan, S, Dancso, B, Dastidar, AG, et al.. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med 2017;12:147–55. https://doi.org/10.1007/s11739-017-1612-1.Search in Google Scholar PubMed PubMed Central
11. Collet, JP, Thiele, H, Barbato, E, Barthelemy, O, Bauersachs, J, Bhatt, DL, et al.. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. Eur Heart J 2021;42:1289–367. https://doi.org/10.1093/eurheartj/ehaa575.Search in Google Scholar PubMed
12. Apple, FS, Jaffe, AS, Collinson, P, Mockel, M, Ordonez-Llanos, J, Lindahl, B, et al.. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015;48:201–3. https://doi.org/10.1016/j.clinbiochem.2014.08.021.Search in Google Scholar PubMed
13. Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures; approved guideline, 3rd ed Berwyn: CLSI Document EP05-A3; 2014.Search in Google Scholar
14. Clinical and Laboratory Standards Institute. Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline, 2nd ed Berwyn: CLSI document EP17-A2; 2012.Search in Google Scholar
15. Clinical and laboratory standards institute. Evaluation of linearity of quantitative measurement procedures, 2nd ed Berwyn: CLSI document EP06; 2020.Search in Google Scholar
16. Clinical and laboratory standards institute. Interference testing in clinical chemistry; approved guideline, 2nd ed Berwyn: CLSI document EP07-A2; 2005.Search in Google Scholar
17. Hammarsten, O, Warner, JV, Lam, L, Kavsak, P, Lindahl, B, Aakre, KM, et al.. Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on clinical applications of cardiac biomarkers. Clin Chem Lab Med 2023;61:1411–9. https://doi.org/10.1515/cclm-2023-0028.Search in Google Scholar PubMed
18. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd ed Berwyn: CLSI Document EP28-A3c; 2010.Search in Google Scholar
19. Bolstad, N, Warren, DJ, Nustad, K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metabol 2013;27:647–61. https://doi.org/10.1016/j.beem.2013.05.011.Search in Google Scholar PubMed
20. Lewis, JG, Connolly, AJL, Ploeg, H, Phillips, IJ, King, RI, Elder, PA, et al.. Grossly elevated false-positive high-sensitivity troponin I due to heterophilic antimouse IgG1 antibodies. J Appl Lab Med 2020;5:815–7. https://doi.org/10.1093/jalm/jfaa024.Search in Google Scholar PubMed
21. Clerico, A, Ripoli, A, Zaninotto, M, Masotti, S, Musetti, V, Ciaccio, M, et al.. Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study. Clin Chim Acta 2019;496:25–34. https://doi.org/10.1016/j.cca.2019.06.012.Search in Google Scholar PubMed
22. Clerico, A, Zaninotto, M, Padoan, A, Masotti, S, Musetti, V, Prontera, C, et al.. Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: from theory to practice. Adv Clin Chem 2019;93:239–62. https://doi.org/10.1016/bs.acc.2019.07.005.Search in Google Scholar PubMed
23. Clerico, A, Zaninotto, M, Aimo, A, Cardinale, DM, Dittadi, R, Sandri, MT, et al.. Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance. Clin Chem Lab Med 2023;61:1209–29. https://doi.org/10.1515/cclm-2022-1285.Search in Google Scholar PubMed
24. Park, JY, Jaffe, AS. Troponin autoantibodies: from assay interferent to mediator of cardiotoxicity. Clin Chem 2017;63:30–2. https://doi.org/10.1373/clinchem.2016.268920.Search in Google Scholar PubMed
25. Nussinovitch, U, Shoenfeld, Y. Anti-troponin autoantibodies and the cardiovascular system. Heart 2010;96:1518–24. https://doi.org/10.1136/hrt.2010.195255.Search in Google Scholar PubMed
26. Saunders, A, Tsui, AKY, Alhulaimi, N. Persistent troponin elevation in the setting of an elevated rheumatoid factor: when it pays to double check. CJC Open 2021;3:981–3. https://doi.org/10.1016/j.cjco.2021.02.014.Search in Google Scholar PubMed PubMed Central
27. Lam, L, Aspin, L, Heron, RC, Ha, L, Kyle, C. Discrepancy between cardiac troponin assays due to endogenous antibodies. Clin Chem 2020;66:445–54. https://doi.org/10.1093/clinchem/hvz032.Search in Google Scholar PubMed
28. Wu, AH, Feng, YJ, Moore, R, Apple, FS, McPherson, PH, Buechler, KF, et al.. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 1998;44:1198–208. https://doi.org/10.1093/clinchem/44.6.1198.Search in Google Scholar
29. Bates, KJ, Hall, EM, Fahie-Wilson, MN, Kindler, H, Bailey, C, Lythall, D, et al.. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem 2010;56:952–8. https://doi.org/10.1373/clinchem.2009.133546.Search in Google Scholar PubMed
30. van Wijk, XMR, Claassen, S, Enea, NS, Li, P, Yang, S, Brouwer, MA, et al.. Cardiac troponin I is present in plasma of type 1 myocardial infarction patients and patients with troponin I elevations due to other etiologies as complex with little free I. Clin Biochem 2019;73:35–43. https://doi.org/10.1016/j.clinbiochem.2019.06.012.Search in Google Scholar PubMed
31. Krintus, M, Kozinski, M, Boudry, P, Capell, NE, Koller, U, Lackner, K, et al.. European multicenter analytical evaluation of the abbott architect stat high sensitive troponin I immunoassay. Clin Chem Lab Med 2014;52:1657–65. https://doi.org/10.1515/cclm-2014-0107.Search in Google Scholar PubMed
32. Christenson, RH, Peacock, WF, Apple, FS, Limkakeng, ATJr., Nowak, RM, McCord, J, et al.. Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: the high-us study. Contemp Clin Trials Commun 2019;14:100337. https://doi.org/10.1016/j.conctc.2019.100337.Search in Google Scholar PubMed PubMed Central
33. Panteghini, M. Standardization of cardiac troponin I measurements: the way forward? Clin Chem 2005;51:1594–7. https://doi.org/10.1373/clinchem.2005.054551.Search in Google Scholar PubMed
34. Panteghini, M, Bunk, DM, Christenson, RH, Katrukha, A, Porter, RA, Schimmel, H, et al.. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008;46:1501–6. https://doi.org/10.1515/cclm.2008.291.Search in Google Scholar PubMed
35. Tate, JR, Bunk, DM, Christenson, RH, Katrukha, A, Noble, JE, Porter, RA, et al.. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010;42:402–8. https://doi.org/10.3109/00313025.2010.495246.Search in Google Scholar PubMed
36. Pretorius, CJ, Dimeski, G, O’Rourke, PK, Marquart, L, Tyack, SA, Wilgen, U, et al.. Outliers as a cause of false cardiac troponin results: investigating the robustness of 4 contemporary assays. Clin Chem 2011;57:710–8. https://doi.org/10.1373/clinchem.2010.159830.Search in Google Scholar PubMed
37. Warner, JV, Marshall, GA. High incidence of macrotroponin I with a high-sensitivity troponin I assay. Clin Chem Lab Med 2016;54:1821–9. https://doi.org/10.1515/cclm-2015-1276.Search in Google Scholar PubMed
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cclm-2023-0529).
© 2023 Walter de Gruyter GmbH, Berlin/Boston
